<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04983420</url>
  </required_header>
  <id_info>
    <org_study_id>Polyphenol</org_study_id>
    <nct_id>NCT04983420</nct_id>
  </id_info>
  <brief_title>Effects of Different Polyphenol-containing Beverages on the Immune System and on Muscular Growth Factors</brief_title>
  <official_title>Effects of Different Polyphenol-containing Beverages on the Immune System and on Muscular Growth Factors - a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Balgrist University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Balgrist University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this research project, the effect of different polyphenol-containing beverages with&#xD;
      varying alcohol content of &lt; 0.4 vol% on immune function as well as muscular growth factors&#xD;
      will be investigated&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>white blood cells</measure>
    <time_frame>before beverage intake</time_frame>
    <description>white blood cell count</description>
  </primary_outcome>
  <primary_outcome>
    <measure>white blood cells</measure>
    <time_frame>60 minutes after intake</time_frame>
    <description>white blood cell count</description>
  </primary_outcome>
  <primary_outcome>
    <measure>white blood cells</measure>
    <time_frame>120 minutes after intake</time_frame>
    <description>white blood cell count</description>
  </primary_outcome>
  <primary_outcome>
    <measure>inflammatory markers in the blood</measure>
    <time_frame>before beverage intake</time_frame>
    <description>IL-6, TNF- α, hs-CRP</description>
  </primary_outcome>
  <primary_outcome>
    <measure>inflammatory markers in the blood</measure>
    <time_frame>60 minutes after intake</time_frame>
    <description>IL-6, TNF- α, hs-CRP</description>
  </primary_outcome>
  <primary_outcome>
    <measure>inflammatory markers in the blood</measure>
    <time_frame>120 minutes after intake</time_frame>
    <description>IL-6, TNF- α, hs-CRP</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood alcohol</measure>
    <time_frame>before beverage intake</time_frame>
    <description>blood alcohol level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood alcohol</measure>
    <time_frame>60 minutes after intake</time_frame>
    <description>blood alcohol level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood alcohol</measure>
    <time_frame>120 minutes after intake</time_frame>
    <description>blood alcohol level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>white blood cells</measure>
    <time_frame>after 14 days of daily intake</time_frame>
    <description>white blood cell count</description>
  </primary_outcome>
  <primary_outcome>
    <measure>inflammatory markers in the blood</measure>
    <time_frame>after 14 days of daily intake</time_frame>
    <description>IL-6, TNF- α, hs-CRP</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood alcohol</measure>
    <time_frame>after 14 days of daily intake</time_frame>
    <description>blood alcohol level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>polyphenol in the urine</measure>
    <time_frame>before beverage intake</time_frame>
    <description>polyphenol level in the urine</description>
  </primary_outcome>
  <primary_outcome>
    <measure>polyphenol in the urine</measure>
    <time_frame>120 minutes after intake</time_frame>
    <description>polyphenol level in the urine</description>
  </primary_outcome>
  <primary_outcome>
    <measure>polyphenol in the urine</measure>
    <time_frame>after 14 days of daily intake</time_frame>
    <description>polyphenol level in the urine</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>dietary habit</measure>
    <time_frame>before beverage intake and day 12-14 of beverage intake</time_frame>
    <description>3 day food diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dietary habit</measure>
    <time_frame>day 12-14 of beverage intake</time_frame>
    <description>3 day food diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical activity</measure>
    <time_frame>before beverage intake</time_frame>
    <description>Global Physical Activity Questionnaire (allows to calculate metabolic equivalents to express the intensity of physical activities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical activity</measure>
    <time_frame>day 14 of beverage intake</time_frame>
    <description>Global Physical Activity Questionnaire (allows to calculate metabolic equivalents to express the intensity of physical activities</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Food Sensitivity</condition>
  <arm_group>
    <arm_group_label>non-alcoholic Pilsner</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 L non-alcoholic Pilsner per day for 2 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-alcoholic wheat beer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 L non-alcoholic wheat beer per day for 2 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>apple spritzer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 L apple spritzer per day for 2 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lemonade</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1 L lemonade per day for 2 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>non-alcoholic Pilsner</intervention_name>
    <description>intake of 1 L non-alcoholic Pilsner per day for 2 weeks</description>
    <arm_group_label>non-alcoholic Pilsner</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>non-alcoholic wheat beer</intervention_name>
    <description>intake of 1 L non-alcoholic wheat beer per day for 2 weeks</description>
    <arm_group_label>non-alcoholic wheat beer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>apple spritzer</intervention_name>
    <description>intake of 1 L apple spritzer per day for 2 weeks</description>
    <arm_group_label>apple spritzer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>lemonade</intervention_name>
    <description>intake of 1 L lemonade per day for 2 weeks</description>
    <arm_group_label>lemonade</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy&#xD;
&#xD;
          -  Age 20 - 60 years&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  severe gastrointestinal disease or known malabsorption&#xD;
&#xD;
          -  use of proton pump inhibitors&#xD;
&#xD;
          -  malignancies&#xD;
&#xD;
          -  rheumatoid diseases&#xD;
&#xD;
          -  metabolic syndrome&#xD;
&#xD;
          -  acute or chronic infections or inflammatory diseases&#xD;
&#xD;
          -  use of medications or supplements to interfere with immune function&#xD;
&#xD;
          -  alcohol and/or drug abuse or addiction&#xD;
&#xD;
          -  dependent relationship with the project manager or his or her employees&#xD;
&#xD;
          -  pregnancy or breastfeeding&#xD;
&#xD;
          -  chronic illness or regular use of medication (except hormonal contraception)&#xD;
&#xD;
          -  smoker&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johannes Scherr, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Balgrist University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Johannes Scherr, Prof</last_name>
    <phone>+41 44 386 11 11</phone>
    <email>johannes.scherr@balgrist.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Regula Schuepbach, MSc</last_name>
    <phone>+41 44 510 73 75</phone>
    <email>regula.schuepbach@balgrist.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Balgrist University Hospital</name>
      <address>
        <city>Zurich</city>
        <zip>8008</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johannes Scherr, Prof</last_name>
      <phone>+41 44 386 11 11</phone>
      <email>johannes.scherr@balgrist.ch</email>
    </contact>
    <contact_backup>
      <last_name>Regula Schuepbach, MSc</last_name>
      <phone>+41 44 510 73 75</phone>
      <email>regula.schuepbach@balgrist.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>May 6, 2021</study_first_submitted>
  <study_first_submitted_qc>July 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2021</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

